Discontinued — last reported Q1 '26
Business Segments · Other Operating Income
Life Sciences — Other Operating Income
This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ1 2026Feb 9, 2026
Rolls up toOther operating expenses
How to read this metric
Frequent or large expenses may indicate recurring operational issues or restructuring, while income may represent one-time gains.
Detailed definition
This captures miscellaneous operating income or expenses for the Life Sciences segment that are not classified as cost o...
Peer comparison
Standard 'other operating' line item found in segment reporting for diversified healthcare firms.
Metric ID:
bdx_segment_life_sciences_other_operating_income_expense_netHistorical Data
10 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.50M | -$1.50M | -$1.50M | -$1.50M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +100.0% | — | — | — | — | — |
| YoY Change | — | — | — | — | +100.0% | +100.0% | +100.0% | +100.0% | — | — |
Range-$1.50M – $0.00
CAGR-100.0%
Avg YoY Growth+100.0%
Median YoY Growth+100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's life sciences — other operating income?
- Becton, Dickinson and Company (BDX) reported life sciences — other operating income of $0.00 in Q4 2025.
- What does life sciences — other operating income mean?
- Net non-core operating income or expenses for the Life Sciences segment.